Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ceftriaxone (1000mg) + Sulbactam (500mg)
Therapeutic Category
Antibacterials, Antibiotic, Dermatology, Gastroenterology, General and OTC medicines, Pulmonary, Respiratory, Urology
Dosage Form
Injection
Packaging Type
Vial
Packaging
1500 mg
Price
₹214/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Fritcet S 1.5g Injection is a combination antibiotic therapy designed to combat a range of bacterial infections. This formulation includes 1000 mg of ceftriaxone, a broad-spectrum cephalosporin antibiotic, and 500 mg of sulbactam, a beta-lactamase inhibitor. Together, they provide effective treatment against both Gram-positive and Gram-negative bacteria, making Fritcet S an ideal choice for serious infections such as pneumonia, skin infections, urinary tract infections, and intra-abdominal infections.
Ceftriaxone works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Sulbactam enhances the efficacy of ceftriaxone by preventing the breakdown of the antibiotic by beta-lactamase enzymes produced by resistant bacteria. This synergy allows for effective treatment where monotherapy may fail.
Common side effects may include gastrointestinal disturbances, rash, allergic reactions, and changes in blood parameters. Serious adverse effects are rare but can include severe allergic reactions and Clostridium difficile-associated diarrhea.
Fritcet S is indicated for the treatment of complicated infections caused by susceptible bacteria, including those in the respiratory tract, urinary tract, skin, and soft tissues.
Before administering Fritcet S, assess the patient's allergy history, especially related to penicillins or cephalosporins. Monitor renal function and ensure proper hydration during treatment. Fritcet S 1.5g Injection is administered intravenously or intramuscularly, with dosage adjustments based on the severity of infection and renal function. It is essential to complete the full course of therapy to prevent the development of antibiotic resistance. Regular monitoring by healthcare professionals is advised to ensure efficacy and safety throughout the treatment period.
Store at controlled room temperature, away from direct light and moisture. Keep out of reach of children.
Composition : Ceftriaxone (1000mg)
Composition : Ceftriaxone (125mg) Injection
Composition : Ceftriaxone (250mg)
Composition : Ceftriaxone (250mg) + Sulbactam (125mg)
Composition : Ceftriaxone (250mg) + Tazobactum (31.25mg)
Composition : Ceftriaxone (500mg)
Composition : Ceftriaxone (500mg) + Sulbactam (250mg)
Composition : Cefuroxime (1500mg)
Composition : Cefuroxime (1.5gm)
Composition : Cefuroxime (1500mg) + Sulbactam (750mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ceftriaxone 1000mg + Sulbactam 500mg Injection has strong demand in the hospital, anti-infective, and critical care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced injectable antibiotics and institutional healthcare portfolios.
Medical distributors and agencies can benefit from consistent demand for moderate to severe bacterial infection management under medical supervision. Ceftriaxone 1000mg is a third-generation cephalosporin antibiotic with broad-spectrum antibacterial activity Sulbactam 500mg is a beta-lactamase inhibitor that enhances antibiotic effectiveness against resistant bacteria Commonly prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, gynecological infections, and hospital-acquired infections Widely used in hospitals, nursing homes, and critical care settings Injectable formulation provides rapid and effective treatment for serious infections This strengthens a robust anti-infective and hospital-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ceftriaxone 1000mg + Sulbactam 500mg Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong hospital demand, institutional procurement opportunities, repeat orders, reliable supply chain support, high market acceptance, and attractive margins in the injectable antibiotic segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.